Abstract:Summary form only given. Plasma medicine is a relatively new field that outgrew from research in application of low-temperature (or cold) atmospheric plasmas in bioengineering. One of the most promising applications of cold atmospheric plasma (CAP) is the cancer therapy. Convincing evidence of CAP selectivity towards the cancel cells has been accumulated. This talk will summarize the state of the art of this emerging field presenting various aspects of CAP application in cancer such as role of reactive species (reactive oxygen and nitrogen), cell cycle modification, in vivo application, CAP interaction with cancer cells in conjunction with nanoparticles, computational oncology applied to CAP.The efficacy of cold plasma in a pre-clinical model of various cancer types such as lung, bladder, breast, head, neck, brain and skin has been demonstrated. Both in-vitro and in-vivo studies revealed that cold plasmas selectively kill cancer cells. It was shown that: (a) cold plasma application selectively eradicates cancer cells in vitro without damaging normal cells. (b) Significantly reduced tumor size in vivo. The two best known cold plasma effects, plasma-induced apoptosis and the decrease of cell migration velocity can have important implications in cancer treatment by localizing the affected area of the tissue and by decreasing metastasic development. In addition, cold plasma treatment has affected the cell cycle of cancer cells. In particular, cold plasma induces a 2-fold increase in cells at the G2/M-checkpoint in both papilloma and carcinoma cells at ~24 hours after treatment, while normal epithelial cells did not show significant differences. It was shown that reactive oxygen species metabolism and oxidative stress responsive genes are deregulated. Effects related to plasma-activated media will be discussed. In particular, recent study shows that by altering the concentration of fetal bovine serum in Dulbecco's modified Eagle's medium and the temperature to store CAP stimulated media, controllable strategies to harness the stimulated media can be developed. Tumor growth and its response to plasma treatment were simulated using a three-dimensional hybrid discrete- continuum model. The results compare untreated and treated tumors of varying sizes by measuring spatiotemporal data to predict trends of tumor evolution. The simulation results show that the treated tumor death, irrespective of tumor volume, follows an exponential decay and that the untreated tumor follows an expected growth pattern.

[Effects of Glycyrrhiza Extract on Pharmacokinetics Property of Daphnetin in Rats].

Pharmacokinetics of Ginsenosides Rg1, Re and Notoginsenoside R1 in Rats by an in vivo Microdialysis Coupled with Liquid Chromatography/Mass Spectrometry

The Effect of Diltiazern on Patency Rate of Arteriovenous Anastomosis in Rat and How It Works

Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats

Effect of Astragali Radix Extract on Pharmacokinetic Behavior of Dapagliflozin in Healthy and Type 2 Diabetic Rats

Pharmacokinetic Comparative Study of Gastrodin and Rhynchophylline after Oral Administration of Different Prescriptions Ofyizhitablets in Rats by an HPLC-ESI/MS Method

[Therapeutic effect of aqueous-extract from a traditional Chinese medical herb Drynaria fortunei on rat experimental model of alveolar bone resorption].

Comparative pharmacokinetics of gastrodin in rats after intragastric administration of free gastrodin, parishin and Gastrodia elata extract

Comparison of Pharmacokinetics of Ginkgolide B Monomer and Extract of Ginkgolides in Rats

Effects of glycyrrhizin on the pharmacokinetics of paeoniflorin in rats and its potential mechanism

Pharmacokinetics Comparison of 15 Ginsenosides and 3 Aglycones in Ginseng Radix Et Rhizoma and Baoyuan Decoction Using Ultra-Fast Liquid Chromatography Coupled with Triple Quadrupole Tandem Mass Spectrometry.

Mechanism of Daphnetin Absorption Across Caco-2 Monolayer Model

Kinetics Absorption Characteristics of Ferrous Glycinate in SD Rats and Its Impact on the Relevant Transport Protein

Multi-Component Comparative Pharmacokinetics in Rats After Oral Administration of Fructus aurantii Extract, Naringin, Neohesperidin, and Naringin-Neohesperidin

Pharmacokinetic Comparisons of Six Components from Raw and Vinegar-Processed Daphne Genkwa Aqueous Extracts Following Oral Administration in Rats by Employing UHPLC-MS/MS Approaches.

Dmd064881 1702..1710

Bombesin-like peptide is present in duct cells in salivary glands: studies on normal and irradiated animals

Pharmacokinetics and Tissue Distribution Study of Daphnoretin in Ethanol Extract from the Roots of Wikstroemia Indica in Rats by a Validated UPLC-MS/MS Method

Identification and Characterization of Human UDP-glucuronosyltransferases Responsible for the in Vitro Glucuronidation of Daphnetin.

Simultaneous Determination of Luteoloside, Apigetrin, And Hesperidin In Rat Plasma By UHPLC-MS/MS: Application to A Comparative Pharmacokinetic Investigation After Oral Administration Of Schizonepeta Tenuifolia Aqueous Extract With And Without Its Volatile Oil

Cold plasma application in cancer therapy